These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16855454

  • 21. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B, Waubant E, Confavreux C, Edan G, Debouverie M, Rumbach L, Moreau T, Pelletier J, Lubetzki C, Clanet M, French Modafinil Study Group.
    Neurology; 2005 Apr 12; 64(7):1139-43. PubMed ID: 15824337
    [Abstract] [Full Text] [Related]

  • 22. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
    Jones DE, Newton JL.
    Aliment Pharmacol Ther; 2007 Feb 15; 25(4):471-6. PubMed ID: 17270003
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients.
    Chan KM, Strohschein FJ, Rydz D, Allidina A, Shuaib A, Westbury CF.
    Muscle Nerve; 2006 Jan 15; 33(1):138-41. PubMed ID: 16175627
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R, Hosseini M, Ghanizadeh A, Ghaleiha A, Tabrizi M, Raznahan M, Golalizadeh M, Akhondzadeh S.
    Depress Anxiety; 2011 Apr 15; 28(4):297-302. PubMed ID: 21456039
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.
    Jha A, Weintraub A, Allshouse A, Morey C, Cusick C, Kittelson J, Harrison-Felix C, Whiteneck G, Gerber D.
    J Head Trauma Rehabil; 2008 Apr 15; 23(1):52-63. PubMed ID: 18219235
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A.
    Addiction; 2009 Feb 15; 104(2):224-33. PubMed ID: 19149817
    [Abstract] [Full Text] [Related]

  • 33. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
    DeBattista C, Doghramji K, Menza MA, Rosenthal MH, Fieve RR, Modafinil in Depression Study Group.
    J Clin Psychiatry; 2003 Sep 15; 64(9):1057-64. PubMed ID: 14628981
    [Abstract] [Full Text] [Related]

  • 34. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
    Thase ME, Fava M, DeBattista C, Arora S, Hughes RJ.
    CNS Spectr; 2006 Feb 15; 11(2):93-102. PubMed ID: 16520686
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial.
    Vasconcelos OM, Prokhorenko OA, Salajegheh MK, Kelley KF, Livornese K, Olsen CH, Vo AH, Dalakas MC, Halstead LS, Jabbari B, Campbell WW.
    Neurology; 2007 May 15; 68(20):1680-6. PubMed ID: 17502549
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
    Rabkin JG, Gordon PH, McElhiney M, Rabkin R, Chew S, Mitsumoto H.
    Muscle Nerve; 2009 Mar 15; 39(3):297-303. PubMed ID: 19208404
    [Abstract] [Full Text] [Related]

  • 40. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD, Bodkin JA.
    J Clin Psychopharmacol; 2006 Dec 15; 26(6):579-86. PubMed ID: 17110814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.